Pharming Group N.V. (PHAR) Gross margin 2019–2025
Pharming Group N.V. (PHAR) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.9%FY2025 · since FY2019: 87.4% → 87.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.9% | -0.2 pp |
| FY2024 | 88.1% | -1.6 pp |
| FY2023 | 89.7% | -1.7 pp |
| FY2022 | 91.5% | +2.1 pp |
| FY2021 | 89.4% | +0.5 pp |
| FY2020 | 88.9% | +1.5 pp |
| FY2019 | 87.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice